CD79A and irritable bowel syndrome: In another study involving 122 pediatric patients with IBD, the pANCA positivity rate was significantly higher in the UC group (69.9%) than in the CD group (30.4%), and the positivity rates of ASCA IgA (76.2%) and ASCA IgG (94.4%) were significantly higher in the CD group than in the control group.